MedKoo Cat#: 597598 | Name: 3'-Rhamnopiericidin A1

Description:

WARNING: This product is for research use only, not for human or veterinary use.

3'-Rhamnopiericidin A(1) is a piericidin rhamnoside from Streptomyces.

Chemical Structure

3'-Rhamnopiericidin A1
3'-Rhamnopiericidin A1
CAS#131622-62-3

Theoretical Analysis

MedKoo Cat#: 597598

Name: 3'-Rhamnopiericidin A1

CAS#: 131622-62-3

Chemical Formula: C31H47NO8

Exact Mass: 561.3302

Molecular Weight: 561.71

Elemental Analysis: C, 66.29; H, 8.43; N, 2.49; O, 22.79

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
3'-Rhamnopiericidin A(1); 3'-Rhamnopiericidin A1; SN-198-C;
IUPAC/Chemical Name
(2S,3R,4R,5R,6S)-2-((2-((2E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl)-5,6-dimethoxy-3-methylpyridin-4-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
InChi Key
ZIBGPNICZWZARG-TWWKIJBXSA-N
InChi Code
InChI=1S/C31H47NO8/c1-10-19(4)24(33)20(5)16-18(3)13-11-12-17(2)14-15-23-21(6)28(29(37-8)30(32-23)38-9)40-31-27(36)26(35)25(34)22(7)39-31/h10-11,13-14,16,20,22,24-27,31,33-36H,12,15H2,1-9H3/b13-11+,17-14+,18-16+,19-10+/t20-,22+,24+,25+,26-,27-,31+/m1/s1
SMILES Code
O[C@H]([C@@H]([C@H]([C@H](C)O1)O)O)[C@@H]1OC2=C(C)C(C/C=C(C)/C/C=C/C(C)=C/[C@@H](C)[C@@H](O)/C(C)=C/C)=NC(OC)=C2OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 561.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Takizawa T, Shibata M, Kayama Y, Toriumi H, Ebine T, Koh A, Shimizu T, Suzuki N. Temporal profiles of high-mobility group box 1 expression levels after cortical spreading depression in mice. Cephalalgia. 2016 Jan;36(1):44-52. doi: 10.1177/0333102415580100. Epub 2015 Apr 10. PubMed PMID: 25862357. 2: Choudhary SV, Aghi T, Bisati S. Efficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris. Indian Dermatol Online J. 2014 Apr;5(2):128-31. doi: 10.4103/2229-5178.131079. PubMed PMID: 24860743; PubMed Central PMCID: PMC4030336. 3: Luo M, Fu L. The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response. Oncotarget. 2016 May 17;7(20):29794-803. doi: 10.18632/oncotarget.7631. Review. PubMed PMID: 26919108; PubMed Central PMCID: PMC5045434. 4: Pei S, Zhao F, Liu J, Fu Q, Shang P. Association between regulator of telomere elongation helicase 1 polymorphism and susceptibility to glioma. Int J Clin Exp Med. 2015 Jan 15;8(1):690-7. eCollection 2015. PubMed PMID: 25785045; PubMed Central PMCID: PMC4358500. 5: Syro LV, Scheithauer BW, Kovacs K, Toledo RA, Londoño FJ, Ortiz LD, Rotondo F, Horvath E, Uribe H. Pituitary tumors in patients with MEN1 syndrome. Clinics (Sao Paulo). 2012;67 Suppl 1:43-8. Review. PubMed PMID: 22584705; PubMed Central PMCID: PMC3328811. 6: Li M, Jiang J, Fu B, Chen J, Xue Q, Dong W, Gu Y, Tang L, Xue L, Fang Q, Wang M, Zhang X. PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis. Neural Regen Res. 2013 Dec 15;8(35):3296-305. doi: 10.3969/j.issn.1673-5374.2013.35.004. PubMed PMID: 25206651; PubMed Central PMCID: PMC4145942. 7: Shingai R, Sutherland ML, Barnard EA. Effects of subunit types of the cloned GABAA receptor on the response to a neurosteroid. Eur J Pharmacol. 1991 Jan 25;206(1):77-80. PubMed PMID: 1676682. 8: Krompholz H, Fischer H. Nanosecond high radiance standard source. Appl Opt. 1974 Jan 1;13(1):203-5. doi: 10.1364/AO.13.000203. PubMed PMID: 20125946. 9: Defilippi P, van Hinsbergh V, Bertolotto A, Rossino P, Silengo L, Tarone G. Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells. J Cell Biol. 1991 Aug;114(4):855-63. PubMed PMID: 1869591; PubMed Central PMCID: PMC2289904. 10: Kawamura-Konishi Y, Suzuki H. Interaction between alpha 1 and beta 1 subunits of human hemoglobin. Biochem Biophys Res Commun. 1988 Oct 14;156(1):348-54. PubMed PMID: 3178839. 11: Maury CP, Andersson LC, Teppo AM, Partanen S, Juvonen E. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis. 1988 Dec;47(12):972-8. PubMed PMID: 3264697; PubMed Central PMCID: PMC1003648. 12: Carver W, Molano I, Reaves TA, Borg TK, Terracio L. Role of the alpha 1 beta 1 integrin complex in collagen gel contraction in vitro by fibroblasts. J Cell Physiol. 1995 Nov;165(2):425-37. PubMed PMID: 7593221. 13: Rossino P, Defilippi P, Silengo L, Tarone G. Up-regulation of the integrin alpha 1/beta 1 in human neuroblastoma cells differentiated by retinoic acid: correlation with increased neurite outgrowth response to laminin. Cell Regul. 1991 Dec;2(12):1021-33. PubMed PMID: 1839359; PubMed Central PMCID: PMC361902. 14: Riikonen T, Vihinen P, Potila M, Rettig W, Heino J. Antibody against human alpha 1 beta 1 integrin inhibits HeLa cell adhesion to laminin and to type I, IV, and V collagens. Biochem Biophys Res Commun. 1995 Apr 6;209(1):205-12. PubMed PMID: 7726837. 15: Nagavarapu U, Relloma K, Herron GS. Membrane type 1 matrix metalloproteinase regulates cellular invasiveness and survival in cutaneous epidermal cells. J Invest Dermatol. 2002 Apr;118(4):573-81. PubMed PMID: 11918701. 16: Polna I, Cendrowski W, Niedźwiedzka E. Elevated parainfluenza virus type 1 antibody in patients with subacute sclerosing panencephalitis. J Neurol Sci. 1977 Jan-Feb;31(1):159-61. PubMed PMID: 188993. 17: Benkoël L, Benoliel AM, Brisse J, Sastre B, Bongrand P, Chamlian A. Immunocytochemical study of NA+ K(+)-ATPase alpha 1 and beta 1 subunits in human and rat normal hepatocytes using confocal microscopy. Cell Mol Biol (Noisy-le-grand). 1995 Jun;41(4):499-504. PubMed PMID: 7549786. 18: Xia M, Zhu Y. Expression of integrin subunits in the herniated intervertebral disc. Connect Tissue Res. 2008;49(6):464-9. doi: 10.1080/03008200802325425. PubMed PMID: 19085247. 19: Tiberti C, Dotta F, Anastasi E, Torresi P, Multari G, Vecci E, Andreani D, Di Mario U. Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects. Autoimmunity. 1995;22(1):43-8. PubMed PMID: 8882421. 20: Tawil NJ, Wilson P, Carbonetto S. Expression and distribution of functional integrins in rat CNS glia. J Neurosci Res. 1994 Nov 1;39(4):436-47. PubMed PMID: 7533845.